| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.68 | 0.01 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.54 | 0.06 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.52 | 0.003 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.49 | 0.004 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.08 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.33 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.31 | 0.06 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.29 | 0.07 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.24 | 0.2 |